Table 2.
Results of response rates in subgroup subjects treated with methylphenidate and atomoxetine
| Methylphenidate [% (n/N)] | Atomoxetine [% (n/N)] | OR (95% CI) | p-Value | |
|---|---|---|---|---|
| Sex | ||||
| Male | 85.2 (396/465) | 62.7 (261/416) | 3.40 (2.47–4.72) | < 0.01 |
| Female | 80.9 (55/68) | 66.7 (48/72) | 2.09 (0.97–4.70) | 0.060 |
| Age, years | ||||
| < 8 | 83.3 (185/222) | 60.9 (131/215) | 3.19 (2.05–5.04) | < 0.01 |
| 8–10 | 85.8 (187/218) | 65.4 (136/208) | 3.18 (1.99–5.17) | < 0.01 |
| ≥ 10 | 84.9 (79/93) | 64.6 (42/65) | 3.06 (1.43–6.72) | < 0.01 |
| ADHD presentation | ||||
| Combined | 85.3 (226/265) | 64.6 (146/226) | 2.87 (1.88–4.42) | < 0.01 |
| Inattentive | 84.1 (207/246) | 62.4 (148/237) | 3.18 (2.08–4.94) | < 0.01 |
| Hyperactive/impulsive | 81.8 (18/22) | 60.0 (15/25) | 2.88 (0.77–12.76) | 0.118 |
OR odds ratio, CI confidence interval, ADHD attention-deficit hyperactivity disorder